225 results on '"Behrens, Frank"'
Search Results
2. Cost-Effective Platform for the Acquisition of Vital Signs
3. Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE
4. A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
5. ALISTER – Application for lipid stability evaluation and research
6. Machine learning identifies right index finger tenderness as key signal of DAS28-CRP based psoriatic arthritis activity
7. Development of a Low-Cost Open Platform for Vital Signs Acquisition and Monitoring
8. PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis
9. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial
10. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units
11. Correction: Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes
12. Ustekinumab Is Rapid-Acting and Is an Effective Long-Term Treatment for Patients with Active Psoriatic Arthritis: Real-World Evidence from the Non-interventional SUSTAIN Study
13. Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial
14. An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
15. Monitoring and Control of Electrical Machines Using IoT
16. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
17. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial
18. Sensory testing and topical capsaicin can characterize patients with rheumatoid arthritis
19. Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes
20. Development of a Low-Cost Open Platform for Vital Signs Acquisition and Monitoring
21. Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study
22. Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52
23. Behandlung der Psoriasis mit Secukinumab: Praxisrelevante Hinweise
24. Monitoring and Control of Electrical Machines Using IoT
25. The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials
26. Ixekizumab im Vergleich zu Fumarsäureestern und Methotrexat bei der Behandlung der Nagelpsoriasis bei Patienten mit mittelschwerer bis schwerer Psoriasis
27. Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
28. Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate‐to‐severe psoriasis
29. Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern
30. Implementing an automated monitoring process in a digital, longitudinal observational cohort study
31. Correction to: Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52
32. Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study.
33. Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: limitations and opportunities
34. Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries
35. Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting
36. Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study
37. Machine learning identifies right index finger tenderness as key signal of DAS28- CRP based psoriatic arthritis activity
38. Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study
39. The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate
40. Solar-Energie für alle.
41. The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate.
42. Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial.
43. Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting.
44. POS0881 Specific AI-Generated Pattern of Tender Joints and Tenderness at Enthesial Sites are Predictive for Objective Detection of Musculoskeletal Inflammation in Psoriasis Patients
45. Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA
46. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial
47. Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis
48. PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis
49. Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
50. Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.